Patents by Inventor Xiangsong ZHANG

Xiangsong ZHANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12162811
    Abstract: An F-18 labeled chiral pure derivative of hydroxyfuran, a preparation method and use thereof were provided. (4R, 5R)[18F]FAA provided by the present disclosure is a chiral pure radioactive compound, and three other chiral pure [18F]FAA structural formulae are also provided by the present disclosure. The present disclosure provides a chiral pure radioactive probe (4R, 5R)[18F]FAA, which shows unique tumor diagnostic efficiency and similar distribution to AA, and can be used for early diagnosis of tumors, pathological studies, assessment of disease progression, and evaluation for efficacy.
    Type: Grant
    Filed: May 25, 2023
    Date of Patent: December 10, 2024
    Assignee: The First Affiliated Hospital of Sun Yat-sen University
    Inventors: Zhihao Zha, Xiangsong Zhang, Renbo Wu, Jianbo Liu
  • Publication number: 20240182381
    Abstract: An F-18 labeled chiral pure derivative of hydroxyfuran, a preparation method and use thereof were provided. (4R, 5R)[18F]FAA provided by the present disclosure is a chiral pure radioactive compound, and three other chiral pure [18F]FAA structural formulae are also provided by the present disclosure. The present disclosure provides a chiral pure radioactive probe (4R, 5R)[18F]FAA, which shows unique tumor diagnostic efficiency and similar distribution to AA, and can be used for early diagnosis of tumors, pathological studies, assessment of disease progression, and evaluation for efficacy.
    Type: Application
    Filed: May 25, 2023
    Publication date: June 6, 2024
    Applicant: The First Affiliated Hospital of Sun Yat-sen University
    Inventors: Zhihao ZHA, Xiangsong ZHANG, Renbo WU, Jianbo LIU